Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment
Top Cited Papers
- 30 June 2013
- journal article
- review article
- Published by Elsevier BV in Contraception
- Vol. 87 (6), 706-727
- https://doi.org/10.1016/j.contraception.2012.12.011
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular functionVascular Pharmacology, 2011
- Normal vitamin D and low free estradiol levels in women on enzyme-inducing antiepileptic drugsEpilepsy & Behavior, 2011
- Antibiotics and oral contraceptive failure — a case-crossover studyContraception, 2011
- A cohort study of oral contraceptive use and risk of benign breast diseaseInternational Journal of Cancer, 1999
- Metabolism of 17 α-ethynylestradiol in humansLife Sciences, 1990
- The Reduction in Risk of Ovarian Cancer Associated with Oral-Contraceptive UseThe New England Journal of Medicine, 1987
- Epidemiology and endocrinology of benign breast diseaseBreast Cancer Research and Treatment, 1985
- Myocardial infarction, oral contraception, cigarette smoking, and coronary artery spasm in young womenAmerican Heart Journal, 1983
- Effect of Estrogen/Progestin Potency on Lipid/Lipoprotein CholesterolThe New England Journal of Medicine, 1983
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896